Skip to content

Clinical trials

Completed Schizophrenia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: China Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20052
20065
20073
20089
20093
20106
20112
20127
20134
20144
20152
20164
20179
20186
20194
20207
20216
20224
20237
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed104

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center18
Central South University13
Beijing HuiLongGuan Hospital9
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.6
Otsuka Beijing Research Institute5
Tianjin Anding Hospital5
Janssen Research & Development, LLC4
Xian-Janssen Pharmaceutical Ltd.4
AstraZeneca3
Anhui Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia104
Bipolar Disorder3
Cognitive Dysfunction3
Metabolic Syndrome3
Tardive Dyskinesia3
Hyperprolactinemia2
Major Depressive Disorder2
Psychomotor Agitation2
Psychotic Disorders2
Cognition Disorders1

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.